Ratings Surperformance

Trader
Investor
Global
Quality
ESG MSCI
AAA
Ratings Surperformance© - IDEXX Laboratories, Inc.

Ratings ESG MSCI

Ratings ESG MSCI - IDEXX Laboratories, Inc.

Ratings IDEXX Laboratories, Inc.: Strengths and Weaknesses

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • According to MSCI, the company's ESG score for its industry is good.
Highlights: IDEXX Laboratories, Inc.
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Historically, the company has been releasing figures that are above expectations.
Weaknesses: IDEXX Laboratories, Inc.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.91 times its estimated earnings per share for the ongoing year.
  • Based on current prices, the company has particularly high valuation levels.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

Rating Financials

IDEXX Laboratories, Inc. SectorUnited States

Fundamentals

Growth

Revenue growth

EPS growth

FCF growth

Profitability

EBITDA Margin

EBIT Margin

Net Margin

Capital Efficiency

ROA

ROCE

ROE

Financial Health

Gearing

Leverage

Capital Intensity

Balance sheet growth

Long Term balance sheet growth

Long term revenue growth

Long term EPS growth

More ratings
Fundamental Rankings - IDEXX Laboratories, Inc.

Rating Valuation

IDEXX Laboratories, Inc. SectorUnited States

Global Valuation

Enterprise Value

EV/Revenue

EV/EBITDA

EV/FCF

Equity Valuation

P/E

PBR

Dividend Yield

-

EV/EBIT

CAPEX/Revenue

More ratings
Fundamental Rankings - IDEXX Laboratories, Inc.

Rating Consensus

IDEXX Laboratories, Inc. SectorUnited States

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (1 year)

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (1 year)

Analysts' target price evolution (4 months)

Analysts' recommendations evolution (7 days)

Target Price evolution (7 days)

More ratings
Fundamental Rankings - IDEXX Laboratories, Inc.

Rating Business Predictability

IDEXX Laboratories, Inc. SectorUnited States

Visibility

Analysts' coverage

Financial estimates divergence

Analysts' recommendations divergence

Analysts' Target price divergence

Surprise rates

Fundamental Rankings - IDEXX Laboratories, Inc.

Rating Revisions

IDEXX Laboratories, Inc. SectorUnited States

Financial revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

EPS revisions (1 year)

EPS revisions (4 months)

EPS revisions (7 days)

Revenue revisions (7 days)

More ratings
Fundamental Rankings - IDEXX Laboratories, Inc.


Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
40.6B
AAA
170B
BBB
111B
BBB
107B
AA
75.95B
AA
60.37B
AA
53.53B
AAA
49.11B
A
31.47B
BBB
31.19B
A
Average 73.02B
AA
Weighted average by Cap.
AA
  1. Stock Market
  2. Stocks
  3. IDXX Stock
  4. Ratings IDEXX Laboratories, Inc.